1.Carotid Artery Disease in Patients with Arteriosclerosis Obliterans or Aortic Aneurysm.
Hiroyuki Fukushima ; Shin Ishimaru ; Mikihiko Itho ; Hiroaki Ichihashi ; Susumu Makimura ; Hisahito Takae ; Yoshihide Yao ; Takashi Uchino
Japanese Journal of Cardiovascular Surgery 1998;27(3):148-152
In order to assess the prevalence of carotid artery disease in patients with arteriosclerosis obliterans (ASO) or aortic aneurysm, 142 patients underwent screening for the presence of carotid atherosclerosis (plaque) with B-mode ultrasonography. Seventy-four (87.1%) of the 85 patients with ASO and 37 (64.9%) of the 57 patients with aortic aneurysm had carotid artery lesions. Of these patients, about half had bilateral lesions. The differences in the prevalence of carotid lesions were not significantly related to age or sex. Prevalence did not differ in relation to the severity or location of the primary lesions. The majority of the carotid lesions were located in the internal carotid arteries. The prevalence of carotid lesions was higher among patients with cerebral infarction than in those without any lesions on computed tomography. These results showing high prevalence of carotid lesions in ASO and aortic aneurysm suggest the usefulness of routine carotid ultrasonographic screening and also that it is important in order to determine the correct treatment for these cases.
2.Total Cholesterol Level for Assessing Pancreatic Insufficiency Due to Chronic Pancreatitis.
Kenji HIRANO ; Tomotaka SAITO ; Suguru MIZUNO ; Minoru TADA ; Naoki SASAHIRA ; Hiroyuki ISAYAMA ; Miho MATSUKAWA ; Gyotane UMEFUNE ; Dai AKIYAMA ; Kei SAITO ; Shuhei KAWAHATA ; Naminatsu TAKAHARA ; Rie UCHINO ; Tsuyoshi HAMADA ; Koji MIYABAYASHI ; Dai MOHRI ; Takashi SASAKI ; Hirofumi KOGURE ; Natsuyo YAMAMOTO ; Yosuke NAKAI ; Kazuhiko KOIKE
Gut and Liver 2014;8(5):563-568
BACKGROUND/AIMS: To determine the nutritional markers important for assessing the degree of pancreatic insufficiency due to chronic pancreatitis in routine clinical practice. METHODS: A total of 137 patients with chronic pancreatitis were followed up for more than 1 year. They were divided into two groups: a pancreatic diabetes mellitus (DM) group, consisting of 47 patients undergoing medical treatment for DM of pancreatic origin, and a nonpancreatic DM group, consisting of 90 other patients (including 86 patients without DM). Serum albumin, prealbumin, total cholesterol, cholinesterase, magnesium, and hemoglobin were compared between the two groups. RESULTS: The total cholesterol was significantly lower in the pancreatic than the nonpancreatic DM group (164 mg/dL vs 183 mg/dL, respectively; p=0.0028). Cholinesterase was significantly lower in the former group (263 U/L vs 291 U/L, respectively; p=0.016). Among the 37 patients with nonalcoholic pancreatitis, there was no difference in the cholinesterase levels between the pancreatic and nonpancreatic (296 U/L vs 304 U/L, respectively; p=0.752) DM groups, although cholesterol levels remained lower in the former (165 mg/dL vs 187 mg/dL, respectively; p=0.052). CONCLUSIONS: Cholinesterase levels are possibly affected by concomitant alcoholic liver injury. The total cholesterol level should be considered when assessing pancreatic insufficiency due to chronic pancreatitis.
Adult
;
Aged
;
Aged, 80 and over
;
Cholesterol/*blood
;
Cholinesterases/blood
;
Diabetes Mellitus, Type 2/complications
;
Exocrine Pancreatic Insufficiency/*blood/etiology
;
Female
;
Follow-Up Studies
;
Humans
;
Liver Cirrhosis, Alcoholic/blood
;
Male
;
Middle Aged
;
Nutritional Status
;
Pancreas/enzymology
;
Pancreatitis, Alcoholic/blood/complications
;
Pancreatitis, Chronic/blood/*complications
;
Serum Albumin/analysis
3.A Novel, Fully Covered Laser-Cut Nitinol Stent with Antimigration Properties for Nonresectable Distal Malignant Biliary Obstruction: A Multicenter Feasibility Study.
Hiroyuki ISAYAMA ; Kazumichi KAWAKUBO ; Yousuke NAKAI ; Kouta INOUE ; Chimyon GON ; Saburo MATSUBARA ; Hirofumi KOGURE ; Yukiko ITO ; Takeshi TSUJINO ; Suguru MIZUNO ; Tsuyoshi HAMADA ; Rie UCHINO ; Koji MIYABAYASHI ; Keisuke YAMAMOTO ; Takashi SASAKI ; Natsuyo YAMAMOTO ; Kenji HIRANO ; Naoki SASAHIRA ; Minoru TADA ; Kazuhiko KOIKE
Gut and Liver 2013;7(6):725-730
BACKGROUND/AIMS: Stent migration occurs frequently, but the prevention of complications resulting from covered self-expandable metal stents (C-SEMSs) remains unresolved. We prospectively assessed a newly developed C-SEMS, a modified covered Zeo stent (m-CZS), in terms of its antimigration effect. METHODS: Between February 2010 and January 2011, an m-CZS was inserted into 42 patients (31 initial drainage cases and 11 reintervention cases) at a tertiary referral center and three affiliated hospitals. The laser-cut stent was flared for 1.5 cm at both ends, with a 1 cm raised bank located 1 cm in from each flared end. The main outcome of this study was the rate of stent migration, and secondary outcomes were the rate of recurrent biliary obstruction (RBO), the time to RBO, the frequencies of complications, and overall survival. RESULTS: Of the 31 patients with initial drainage, stent migration occurred in four (12.9%, 95% confidence interval, 5.1% to 29.0%), with a mean time of 131 days. RBO occurred in 18 (58%), with a median time to RBO of 107 days. Following previous C-SEMS migration, seven of 10 patients (70%) did not experience m-CZS migration until death. CONCLUSIONS: m-CZSs with antimigration properties effectively, although not completely, prevented stent migration after stent insertion.
Aged
;
Aged, 80 and over
;
Alloys
;
Carcinoma/*complications
;
Cholestasis/etiology/*therapy
;
Digestive System Neoplasms/*complications
;
Drainage
;
Equipment Design
;
Feasibility Studies
;
Female
;
Humans
;
Kaplan-Meier Estimate
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
*Prosthesis Failure
;
Recurrence
;
Reoperation
;
*Stents/adverse effects
;
Time Factors